Plexus Corp. $PLXS Shares Sold by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. reduced its stake in Plexus Corp. (NASDAQ:PLXS) by 9.0% during the 1st quarter, HoldingsChannel.com reports. The firm owned 43,325 shares of the technology company’s stock after selling 4,300 shares during the period. Hillsdale Investment Management Inc.’s holdings in Plexus were worth $8,775,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Emerald Mutual Fund Advisers Trust purchased a new stake in Plexus in the first quarter valued at $20,715,000. Emerald Advisers LLC purchased a new position in shares of Plexus during the first quarter worth about $33,729,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in shares of Plexus by 6.0% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,858 shares of the technology company’s stock worth $376,000 after purchasing an additional 105 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Plexus by 2.3% during the first quarter. Principal Financial Group Inc. now owns 153,392 shares of the technology company’s stock worth $31,068,000 after purchasing an additional 3,477 shares in the last quarter. Finally, Fifth Third Bancorp lifted its holdings in shares of Plexus by 6,710.3% in the 1st quarter. Fifth Third Bancorp now owns 13,825 shares of the technology company’s stock valued at $2,800,000 after purchasing an additional 13,622 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Insider Activity at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 3,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $268.45, for a total value of $805,350.00. Following the transaction, the chief executive officer directly owned 74,888 shares of the company’s stock, valued at approximately $20,103,683.60. The trade was a 3.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $264.75, for a total transaction of $865,732.50. Following the completion of the transaction, the executive vice president directly owned 16,266 shares in the company, valued at $4,306,423.50. This represents a 16.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 21,981 shares of company stock worth $5,855,318 in the last three months. Insiders own 1.78% of the company’s stock.

Plexus Stock Down 3.1%

Plexus stock opened at $259.03 on Tuesday. The stock has a 50 day moving average of $275.87 and a two-hundred day moving average of $224.53. Plexus Corp. has a twelve month low of $115.35 and a twelve month high of $307.06. The stock has a market capitalization of $6.93 billion, a price-to-earnings ratio of 37.87 and a beta of 0.88. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the company posted $1.66 earnings per share. The company’s revenue for the quarter was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, research analysts expect that Plexus Corp. will post 5.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

PLXS has been the subject of a number of research analyst reports. Raymond James Financial reissued an “outperform” rating and issued a $275.00 target price on shares of Plexus in a research report on Thursday, April 30th. Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, July 6th. Benchmark reiterated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Stifel Nicolaus increased their price objective on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Finally, Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $246.67.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.